Review: could Xeloda cause Hardening of the arteries (Atherosclerosis)?
We study 18,060 people who have side effects while taking Xeloda from FDA and social media. Among them, 92 have Hardening of the arteries. Find out below who they are, when they have Hardening of the arteries and more.
Get connected: join a mobile support group for people who take Xeloda and have Hardening of the arteries >>>
Xeloda (latest outcomes from 18,174 users) has active ingredients of capecitabine. It is often used in colon cancer.
Hardening of the arteries
Hardening of the arteries (disorder of the arteries) (latest reports from 78,585 patients) has been reported by people with high blood pressure, osteoporosis, diabetes, pain, arthritis.
On Oct, 30, 2014: 18,060 people reported to have side effects when taking Xeloda. Among them, 92 people (0.51%) have Hardening Of The Arteries.
Time on Xeloda when people have Hardening of the arteries * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
|Hardening of the arteries||40.00%||60.00%||0.00%||0.00%||0.00%||0.00%||0.00% |
Age of people who have Hardening of the arteries when taking Xeloda * :
|Hardening of the arteries||0.00%||0.00%||0.00%||0.00%||0.00%||9.72%||44.44%||45.83% |
Severity of Hardening of the arteries when taking Xeloda ** :
How people recovered from Hardening of the arteries ** :
Top conditions involved for these people * :
- Metastases to bone (44 people, 47.83%)
- Breast cancer (24 people, 26.09%)
- Pain (19 people, 20.65%)
- Depression (15 people, 16.30%)
- Osteoporosis (11 people, 11.96%)
Top co-used drugs for these people * :
- Zometa (84 people, 91.30%)
- Aredia (80 people, 86.96%)
- Femara (56 people, 60.87%)
- Tamoxifen citrate (56 people, 60.87%)
- Faslodex (53 people, 57.61%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Do you have Hardening Of The Arteries while taking Xeloda?
Get connected! Join a mobile support group:
- support group for people who take Xeloda and have Hardening Of The Arteries
- support group for people who take Xeloda
- support group for people who have Hardening Of The Arteries
Can you answer these questions (Ask a question):
More questions for: Xeloda, Hardening of the arteries
More reviews for: Xeloda, Hardening of the arteries
On eHealthMe, Xeloda (capecitabine) is often used for colon cancer. Find out below the conditions Xeloda is used for, how effective it is, and any alternative drugs that you can use to treat those same conditions.
What is Xeloda used for and how effective is it:
Other drugs that are used to treat the same conditions:
Could it be a symptom from a condition:
Drugs in real world that are associated with:
Could your condition cause it?
Related drug studies for: Xeloda, Hardening of the arteries
Recent Xeloda related drug comparison:
More related comparison studies for: Xeloda, Hardening of the arteries
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.